| __timestamp | Amphastar Pharmaceuticals, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 14182353 |
| Thursday, January 1, 2015 | 37065000 | 15503028 |
| Friday, January 1, 2016 | 41199000 | 16183585 |
| Sunday, January 1, 2017 | 43415000 | 22382849 |
| Monday, January 1, 2018 | 57564000 | 33038206 |
| Tuesday, January 1, 2019 | 68853000 | 31777040 |
| Wednesday, January 1, 2020 | 67229000 | 41464134 |
| Friday, January 1, 2021 | 60932000 | 67178053 |
| Saturday, January 1, 2022 | 74771000 | 52531000 |
| Sunday, January 1, 2023 | 73741000 | 68914000 |
In pursuit of knowledge
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Amphastar Pharmaceuticals, Inc. and Pharming Group N.V. have been at the forefront of this financial commitment. From 2014 to 2023, Amphastar's R&D expenses surged by approximately 160%, peaking in 2022. Meanwhile, Pharming Group N.V. demonstrated a remarkable 385% increase in the same period, with a notable spike in 2021. This trend underscores the competitive nature of the industry, where companies are investing heavily to stay ahead. The data reveals that while Amphastar consistently outspent Pharming in the early years, Pharming's aggressive investment strategy in recent years has narrowed the gap significantly. As the pharmaceutical sector continues to innovate, these spending patterns highlight the strategic priorities of these industry players.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
BeiGene, Ltd. vs Pharming Group N.V.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and Pharming Group N.V.
Pharming Group N.V. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Pharming Group N.V. vs Amneal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and Ligand Pharmaceuticals Incorporated
R&D Insights: How Grifols, S.A. and Amphastar Pharmaceuticals, Inc. Allocate Funds
Corcept Therapeutics Incorporated or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.
Protagonist Therapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?